The role of the VEGF family in coronary heart disease

Y Zhou, X Zhu, H Cui, J Shi, G Yuan, S Shi… - Frontiers in …, 2021 - frontiersin.org
The vascular endothelial growth factor (VEGF) family, the regulator of blood and lymphatic
vessels, is mostly investigated in the tumor and ophthalmic field. However, the functions it …

Molecular basis of physiological heart growth: fundamental concepts and new players

M Maillet, JH Van Berlo, JD Molkentin - Nature reviews Molecular cell …, 2013 - nature.com
The heart hypertrophies in response to developmental signals as well as increased
workload. Although adult-onset hypertrophy can ultimately lead to disease, cardiac …

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

M Lohela, M Bry, T Tammela, K Alitalo - Current opinion in cell biology, 2009 - Elsevier
Vascular endothelial growth factors and their endothelial tyrosine kinase receptors are
central regulators of vasculogenesis, angiogenesis and lymphangiogenesis. VEGF …

Vascular endothelial growth factor B controls endothelial fatty acid uptake

CE Hagberg, A Falkevall, X Wang, E Larsson… - Nature, 2010 - nature.com
The vascular endothelial growth factors (VEGFs) are major angiogenic regulators and are
involved in several aspects of endothelial cell physiology. However, the detailed role of …

Cardiovascular gene therapy: past, present, and future

S Ylä-Herttuala, AH Baker - Molecular Therapy, 2017 - cell.com
Cardiovascular diseases remain a large global health problem. Although several
conventional small-molecule treatments are available for common cardiovascular problems …

Regulation of angiogenesis by oxygen and metabolism

P Fraisl, M Mazzone, T Schmidt, P Carmeliet - Developmental cell, 2009 - cell.com
Blood vessels form an important interface between the environment and the organism by
carrying oxygen and nutrients to all cells and thus determining cellular metabolism. It is …

Angiogenic gene therapy in cardiovascular diseases: dream or vision?

S Ylä-Herttuala, C Bridges, MG Katz… - European heart …, 2017 - academic.oup.com
Chronic cardiovascular diseases are significant health problems. Although current treatment
strategies have tremendously improved disease management, up to 30% of these patients …

Cell communications in the heart

D Tirziu, FJ Giordano, M Simons - Circulation, 2010 - Am Heart Assoc
Effective myocardial function depends primarily on oxidative energy production. In humans,
at a heart rate of 60 to 70 beats per minute, the oxygen consumption normalized per gram of …

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

CE Hagberg, A Mehlem, A Falkevall, L Muhl, BC Fam… - Nature, 2012 - nature.com
The prevalence of type 2 diabetes is rapidly increasing, with severe socioeconomic impacts,.
Excess lipid deposition in peripheral tissues impairs insulin sensitivity and glucose uptake …

Vascular endothelial growth factor in heart failure

Z Taimeh, J Loughran, EJ Birks, R Bolli - Nature reviews cardiology, 2013 - nature.com
Heart failure is a devastating condition, the progression of which culminates in a mismatch of
oxygen supply and demand, with limited options for treatment. Heart failure has several …